Culine S - Search Results

1

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial.

Gross-Goupil M, Fourcade A, Blot E, Penel N, Négrier S, Culine S, Chaigneau L, Lesimple T, Priou F, Lortholary A, Kaminsky MC, Provencal J, Voog E, Bouzy J, Laplanche A, Fizazi K. Gross-Goupil M, et al. Among authors: culine s. Eur J Cancer. 2012 Mar;48(5):721-7. doi: 10.1016/j.ejca.2012.01.011. Epub 2012 Feb 6. Eur J Cancer. 2012. PMID: 22317952 Review.

2

Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary.

Culine S, Lhomme C, Kattan J, Duvillard P, Michel G, Droz JP. Culine S, et al. Eur J Cancer. 1994;30A(9):1239-44. doi: 10.1016/0959-8049(94)90165-1. Eur J Cancer. 1994. PMID: 7528029

3

Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave Roussy.

Culine S, Lhomme C, Kattan J, Duvillard P, Michel G, Gerbaulet A, Droz JP. Culine S, et al. Gynecol Oncol. 1995 Sep;58(3):344-8. doi: 10.1006/gyno.1995.1240. Gynecol Oncol. 1995. PMID: 7672699

4

Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.

Kattan J, Culine S, Theodore C, Droz JP. Kattan J, et al. Among authors: culine s. Cancer Invest. 1995;13(3):276-9. doi: 10.3109/07357909509094462. Cancer Invest. 1995. PMID: 7743380 Clinical Trial.

5

Treatment of sarcomatoid renal cell carcinoma: is there a role for chemotherapy?

Culine S, Bekradda M, Terrier-Lacombe MJ, Droz JP. Culine S, et al. Eur Urol. 1995;27(2):138-41. doi: 10.1159/000475145. Eur Urol. 1995. PMID: 7744156 Clinical Trial.

6

Adult Wilms' tumour: review of 22 cases.

Kattan J, Tournade MF, Culine S, Terrier-Lacombe MJ, Droz JP. Kattan J, et al. Among authors: culine s. Eur J Cancer. 1994;30A(12):1778-82. doi: 10.1016/0959-8049(94)00315-v. Eur J Cancer. 1994. PMID: 7880605

7

Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy.

Kattan J, Culine S, Terrier-Lacombe MJ, Théodore C, Droz JP. Kattan J, et al. Among authors: culine s. Ann Oncol. 1993 Dec;4(10):871-5. doi: 10.1093/oxfordjournals.annonc.a058396. Ann Oncol. 1993. PMID: 8117607 Free article. Review.

8

[High dose fosfestrol in phase I-II trial for the treatment of hormone-resistant prostatic adenocarcinoma].

Kattan J, Droz JP, Culine S. Kattan J, et al. Among authors: culine s. Bull Cancer. 1993 Mar;80(3):248-54. Bull Cancer. 1993. PMID: 8173177 Clinical Trial. French.

9

High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours.

Kattan J, Mahjoubi M, Droz JP, Kramar A, Culine S, Boutan-Laroze A, Chazard M. Kattan J, et al. Among authors: culine s. Eur J Cancer. 1993;29A(11):1504-9. doi: 10.1016/0959-8049(93)90283-l. Eur J Cancer. 1993. PMID: 8217352 Clinical Trial.

10

Prognostic factors in non-seminomatous germ cell tumours of the testis. Experience at the Institut Gustave-Roussy.

Kramar A, Droz JP, Rey A, Bouzy J, Philippot I, Culine S. Kramar A, et al. Among authors: culine s. Eur Urol. 1993;23(1):188-95. doi: 10.1159/000474592. Eur Urol. 1993. PMID: 8386648 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

429 results

Search Page